SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-270666
Filing Date
2013-06-25
Accepted
2013-06-25 16:42:02
Documents
3
Period of Report
2013-06-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d560243d8k.htm 8-K 16216
2 EX-99.1 d560243dex991.htm EX-99.1 7258
3 GRAPHIC g560243g27j92.jpg GRAPHIC 4818
  Complete submission text file 0001193125-13-270666.txt   31591
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 13932497
SIC: 2834 Pharmaceutical Preparations